Stocks›Healthcare›ELAN

ELAN Elanco Animal Health Incorporated

NYSEResearch view

Elanco Animal Health Incorporated operates in the Pharmaceutical Preparations industry.

$23.55+0.04%

Oct 16 close · 1D EOD · Databento

HealthcarePharmaceutical PreparationsLarge-capSEC EDGAR FY 2025-12-31

On the WireNo stories on ELAN yet. Follow the company and the next one lands in Following.

What happened

Daily closes · dots are Wire stories

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 5, 2025 and Nov 7, 2024, during the session.

Last report

Aug 5, 2026+2.42%

during the session

Last 4, next close

median 5.29% either way

up 3 of 4

Every report since 2022 →Earnings calendar →

DateEventSourceNext close

Aug 5Earnings release, during the session · 8-KSEC EDGARSEC EDGAR ↗+2.42%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

23 big days in a year, and what we hold on each

A big day is a close more than 4.21% from the one before, three times ELAN’s median day (1.40%). On 0 of the 23, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±4.21%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayELANWhat we hold that dayGroup (median of 4) · each

1 Oct 17, 2025+4.39%
Before our storiesgroup +0.8%, did not move with it
1Oct 17, 2025+4.39%
Before our stories
+0.8% did not move with itABBV +1.2 · MRK +1.0 · JNJ +0.6 · LLY −2.0
2 Nov 21, 2025+4.76%
Before our storiesgroup +2.3%, did not move with it
2Nov 21, 2025+4.76%
Before our stories
+2.3% did not move with itABBV +3.0 · MRK +2.9 · LLY +1.6 · JNJ +0.4
3 Dec 9, 2025−5.81%
Before our storiesgroup −1.2%, did not move with it
3Dec 9, 2025−5.81%
Before our stories
−1.2% did not move with itMRK −2.1 · LLY −1.5 · JNJ −0.8 · ABBV −0.1
4 Dec 10, 2025+4.26%
Before our storiesgroup +1.1%, did not move with it
4Dec 10, 2025+4.26%
Before our stories
+1.1% did not move with itJNJ +3.3 · LLY +1.2 · ABBV +1.0 · MRK +0.8
5 Feb 24, 2026+6.59%
Resultsgroup −0.2%, did not move with it
5Feb 24, 2026+6.59%
ResultsFirst close after the Feb 24 results filing
−0.2% did not move with itJNJ +0.2 · MRK +0.1 · ABBV −0.5 · LLY −1.6
6 Mar 3, 2026−4.64%
Before our storiesgroup −0.9%, did not move with it
6Mar 3, 2026−4.64%
Before our stories
−0.9% did not move with itMRK −1.3 · LLY −1.0 · JNJ −0.7 · ABBV −0.2
7 Mar 17, 2026+7.61%
Before our storiesgroup −1.4%, did not move with it
7Mar 17, 2026+7.61%
Before our stories
−1.4% did not move with itMRK +0.4 · ABBV −0.8 · JNJ −2.1 · LLY −5.9
8 Mar 20, 2026−4.54%
Before our storiesgroup −0.8%, did not move with it
8Mar 20, 2026−4.54%
Before our stories
−0.8% did not move with itLLY −1.2 · JNJ −0.9 · ABBV −0.6 · MRK −0.0
9 Mar 27, 2026−5.90%
Before our storiesgroup −0.1%, did not move with it
9Mar 27, 2026−5.90%
Before our stories
−0.1% did not move with itLLY −2.1 · ABBV −0.8 · JNJ +0.5 · MRK +0.6
10 Apr 21, 2026−4.52%
Before our storiesgroup −1.9%, did not move with it
10Apr 21, 2026−4.52%
Before our stories
−1.9% did not move with itMRK −3.9 · JNJ −2.0 · LLY −1.8 · ABBV +0.7
11 May 6, 2026+13.88%
Resultsgroup −0.3%, did not move with it
11May 6, 2026+13.88%
ResultsFirst close after the May 6 results filing
−0.3% did not move with itMRK +0.4 · LLY −0.2 · JNJ −0.4 · ABBV −0.5
12 May 7, 2026−8.29%
Before our storiesgroup −1.1%, did not move with it
12May 7, 2026−8.29%
Before our stories
−1.1% did not move with itLLY −1.2 · ABBV −1.1 · MRK −1.1 · JNJ −0.9
13 May 11, 2026−8.16%
Before our storiesgroup +0.3%, did not move with it
13May 11, 2026−8.16%
Before our stories
+0.3% did not move with itMRK −0.1 · JNJ +0.1 · ABBV +0.6 · LLY +1.9
14 May 15, 2026−8.23%
Before our storiesgroup −1.0%, did not move with it
14May 15, 2026−8.23%
Before our stories
−1.0% did not move with itMRK −1.8 · JNJ −1.8 · LLY −0.2 · ABBV −0.2
15 May 20, 2026+5.30%
Before our storiesgroup −0.5%, did not move with it
15May 20, 2026+5.30%
Before our stories
−0.5% did not move with itLLY −0.3 · JNJ −0.3 · ABBV −0.7 · MRK −1.1
16 May 26, 2026+5.02%
Before our storiesgroup −1.5%, did not move with it
16May 26, 2026+5.02%
Before our stories
−1.5% did not move with itLLY −0.0 · ABBV −1.2 · JNJ −1.8 · MRK −2.2
17 Jun 5, 2026−4.37%
Before our storiesgroup +0.8%, did not move with it
17Jun 5, 2026−4.37%
Before our stories
+0.8% did not move with itMRK +0.4 · LLY +0.6 · ABBV +1.0 · JNJ +2.0
18 Jun 10, 2026−6.65%
Nothing on ELANgroup −0.3%, did not move with it
18Jun 10, 2026−6.65%
Nothing on ELANNo ELAN story, brief or results filing in our record that day
−0.3% did not move with itLLY −0.7 · MRK −0.4 · ABBV −0.2 · JNJ +0.6
19 Jun 11, 2026+5.16%
Nothing on ELANgroup +0.7%, did not move with it
19Jun 11, 2026+5.16%
Nothing on ELANNo ELAN story, brief or results filing in our record that day
+0.7% did not move with itLLY +2.2 · MRK +1.4 · JNJ −0.1 · ABBV −0.1
20 Aug 6, 2026−7.70%
Nothing on ELANgroup −0.1%, did not move with it
20Aug 6, 2026−7.70%
Nothing on ELANNo ELAN story, brief or results filing in our record that day
−0.1% did not move with itABBV −0.9 · JNJ −0.2 · MRK +0.0 · LLY +1.9
21 Aug 7, 2026−8.60%
Nothing on ELANgroup +0.5%, did not move with it
21Aug 7, 2026−8.60%
Nothing on ELANNo ELAN story, brief or results filing in our record that day
+0.5% did not move with itLLY −0.5 · MRK +0.2 · JNJ +0.9 · ABBV +0.9
22 Aug 14, 2026+5.15%
Nothing on ELANgroup −0.6%, did not move with it
22Aug 14, 2026+5.15%
Nothing on ELANNo ELAN story, brief or results filing in our record that day
−0.6% did not move with itMRK +0.2 · ABBV −0.5 · JNJ −0.7 · LLY −2.4
23 Oct 15, 2026+4.39%
Nothing on ELANgroup −0.1%, did not move with it
23Oct 15, 2026+4.39%
Nothing on ELANNo ELAN story, brief or results filing in our record that day
−0.1% did not move with itLLY +3.5 · ABBV −0.0 · JNJ −0.3 · MRK −1.5

A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in ELAN’s SEC industry; “moved with ELAN” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). ELAN reports during the trading day, so day 1 is that day’s close. 2 of 4 times, day 6 ended on the same side as day 1.

Reported Nov 5, 2025

day 1−4.00%day 6−2.00%

Reported Feb 24, 2026

day 1+6.59%day 6+0.53%

Reported May 6, 2026

day 1+13.88%day 6−5.18%

Reported Aug 5, 2026

day 1+2.42%day 6−13.55%

Next report: expected early NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 5 report: −8.01%. Four reports is a small sample.

Every report since 2022 →

Each line is ELAN’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$11.8B

Revenue$4.7B+6.20%

Net income$-232.0M

EPS, diluted$-0.47−169.10%

Gross margin55.0%

Return on equity-3.5%

Debt / equity0.58

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$11.8B

Enterprise Value$15.0B

Income$-232.0M

Sales$4.7B

Book/sh$13.10

Cash/sh$1.09

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio1.08

Current Ratio2.17

Debt/Eq0.58

EPS (ttm)$-0.47

EPS this Y-169.1%

EPS past 3/5Y—

Sales past 3/5Y2.2%

EPS Y/Y TTM-169.1%

Sales Y/Y TTM6.2%

Shs Outstand499.62M

ROA-1.7%

ROE-3.5%

ROIC—

Gross Margin55.0%

Oper. Margin—

Profit Margin-4.9%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$4.8B

FY21

$4.4B

FY22

$4.4B

FY23

$4.4B

FY24

$4.7B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$4.8B	$4.4B	$4.4B	$4.4B	$4.7B
Gross Profit	—	—	$2.5B	$2.4B	$2.6B
Operating Income	—	—	—	—	—
Net Income	$-483.0M	$-78.0M	$-1.2B	$338.0M	$-232.0M
Diluted EPS	$-0.99	$-0.16	$-2.50	$0.68	$-0.47
Operating Cash Flow	$483.0M	$452.0M	$271.0M	$541.0M	$560.0M
Free Cash Flow	$324.0M	$281.0M	$131.0M	$394.0M	$284.0M

Same industry

ELAN against four drug peers, a year at 100

ELAN is up 9.9% in a year. Merck is up 72.1%, Eli Lilly 56.6%, Johnson & Johnson 32.3% and AbbVie 24.3%. All four did more. Weekly closes, Oct 17, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

ELAN +9.9%. Merck +72.1%, Eli Lilly +56.6%, Johnson & Johnson +32.3%, AbbVie +24.3%. Weekly closes, Oct 17, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in ELAN’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

LLY$1.18T JNJ$615.9B ABBV$504.4B MRK$360.1B ABT$181.5B PFE$168.6B VRTX$126.7B BMY$122.1B

Build basket with ELAN Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.